Steven Cohen Bionomics Limited Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bionomics Limited stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 316,000 shares of BNOX stock, worth $101,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
316,000
Previous 316,000
-0.0%
Holding current value
$101,120
Previous $243,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BNOX
# of Institutions
12Shares Held
1.64MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.23MShares$392,5620.01% of portfolio
-
Ubs Group Ag34.9KShares$11,1670.0% of portfolio
-
Two Sigma Securities, LLC New York, NY26KShares$8,3320.0% of portfolio
-
Two Sigma Investments, LP New York, NY16.4KShares$5,2380.0% of portfolio
-
Xtx Topco LTD London, X010.9KShares$3,5000.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $2.41M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...